Novo Nordisk A/S (NVO)
40.00
+0.86
(+2.20%)
USD |
NYSE |
Oct 30, 16:00
39.94
-0.06
(-0.15%)
Pre-Market: 20:00
Novo Nordisk Total Return Level : 71.58 for Oct. 30, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 30, 2026 | 71.58 |
| October 29, 2026 | 70.04 |
| October 28, 2026 | 68.52 |
| October 27, 2026 | 69.20 |
| October 26, 2026 | 70.02 |
| October 23, 2026 | 69.88 |
| October 22, 2026 | 70.56 |
| October 21, 2026 | 69.90 |
| October 20, 2026 | 70.42 |
| October 19, 2026 | 68.75 |
| October 16, 2026 | 69.49 |
| October 15, 2026 | 70.19 |
| October 14, 2026 | 68.22 |
| October 13, 2026 | 68.11 |
| October 12, 2026 | 69.04 |
| October 09, 2026 | 69.15 |
| October 08, 2026 | 68.32 |
| October 07, 2026 | 68.47 |
| October 06, 2026 | 67.16 |
| October 05, 2026 | 67.18 |
| October 02, 2026 | 66.79 |
| October 01, 2026 | 66.93 |
| September 30, 2026 | 67.84 |
| September 29, 2026 | 68.56 |
| September 28, 2026 | 69.27 |
| Date | Value |
|---|---|
| September 25, 2026 | 69.43 |
| September 24, 2026 | 69.11 |
| September 23, 2026 | 68.31 |
| September 22, 2026 | 70.51 |
| September 21, 2026 | 71.22 |
| September 18, 2026 | 77.38 |
| September 17, 2026 | 77.29 |
| September 16, 2026 | 74.64 |
| September 15, 2026 | 76.11 |
| September 14, 2026 | 77.76 |
| September 11, 2026 | 77.08 |
| September 10, 2026 | 78.76 |
| September 09, 2026 | 79.74 |
| September 08, 2026 | 80.82 |
| September 04, 2026 | 83.39 |
| September 03, 2026 | 85.02 |
| September 02, 2026 | 83.70 |
| September 01, 2026 | 80.74 |
| August 31, 2026 | 81.12 |
| August 28, 2026 | 81.62 |
| August 27, 2026 | 82.78 |
| August 26, 2026 | 84.45 |
| August 25, 2026 | 87.08 |
| August 24, 2026 | 83.97 |
| August 21, 2026 | 83.64 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| AstraZeneca PLC | 471.13 |
| GSK Plc | 188.80 |
| Johnson & Johnson | 651.91 |
| Eli Lilly & Co. | 3745.44 |
| Merck & Co., Inc. | 462.38 |